MEDU-13. FUNCTIONAL CRISPR-CAS9 SCREEN IDENTIFIES DRUGGABLE DEPENDENCIES IN MYC-DRIVEN MEDULLOBLASTOMA

Myc-driven Medulloblastoma remains a major therapeutic challenge due to frequent metastasis and a poor 5-year survival rate. Myc overexpression results in transcriptional dysregulation, proliferation, and survival of malignant cells. However direct inhibition of Myc remains an obstacle to therapeuti...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Neuro Oncol
Päätekijät: Veo, Bethany, Fosmire, Susan, Wang, Dong, Madhavan, Krishna, Pierce, Angela, Venkataraman, Sujatha, Vibhakar, Rajeev
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Oxford University Press 2019
Aiheet:
Medulloblastoma
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC6477310/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/noz036.172
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia